Trade Summary

3 days ago, Hecht Beth, serving as See Remarks at Xeris Biopharma Holdings, Inc. (XERS), sold 16,667 shares at $6.25 per share, for a total transaction value of $104,086.00. Following this transaction, Hecht Beth now holds 1,226,507 shares of XERS.

This sale represents a 1.00% decrease in Hecht Beth's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 4, 2026, 2 days after the trade was made.

Xeris Biopharma Holdings, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.